$RXMD Progressive Care Inc. Announces CEO, Shital
Post# of 42179
(Total Views: 85)
Posted On: 02/14/2019 8:12:17 AM
$RXMD Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Toronto, Canada
MIAMI, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that CEO, Shital Mars will be the keynote speaker at Cold Chain Global Forum in Toronto, Canada February 26- March 1, 2019.
“I am honored to be invited to be keynote speaker at Cold Chain Global Forum presenting on The C-Suite Perspective’s on Top Business Initiatives. I am passionate about representing the pharmacy perspective in an increasingly complex and global pharmaceutical supply chain,” said S. Parikh Mars, CEO of Progressive Care Inc. “We plan to provide valuable insight into the goals and challenges faced by those providing last mile services and solutions.
Cold Chain Global Forum is the largest temperature-controlled life science supply chain event of its kind, focusing specifically on the challenges and opportunities of the Canadian market. It is a unique strategic platform built to ignite discussions about overcoming regulatory challenges, optimizing transportation routes, enhancing collaboration & change management, maintaining temperature-controlled products and implementing new technologies to gain competitive advantage. Progressive Care is proud to lend its voice to leading industry experts on what is needed to maintain medication integrity through the last mile of the supply chain and into the hands of the patient.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Kathleen Gonzales, CMW Media
kathleen@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
MIAMI, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that CEO, Shital Mars will be the keynote speaker at Cold Chain Global Forum in Toronto, Canada February 26- March 1, 2019.
“I am honored to be invited to be keynote speaker at Cold Chain Global Forum presenting on The C-Suite Perspective’s on Top Business Initiatives. I am passionate about representing the pharmacy perspective in an increasingly complex and global pharmaceutical supply chain,” said S. Parikh Mars, CEO of Progressive Care Inc. “We plan to provide valuable insight into the goals and challenges faced by those providing last mile services and solutions.
Cold Chain Global Forum is the largest temperature-controlled life science supply chain event of its kind, focusing specifically on the challenges and opportunities of the Canadian market. It is a unique strategic platform built to ignite discussions about overcoming regulatory challenges, optimizing transportation routes, enhancing collaboration & change management, maintaining temperature-controlled products and implementing new technologies to gain competitive advantage. Progressive Care is proud to lend its voice to leading industry experts on what is needed to maintain medication integrity through the last mile of the supply chain and into the hands of the patient.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Kathleen Gonzales, CMW Media
kathleen@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
(0)
(0)Scroll down for more posts ▼